dalteparin has been researched along with Lichen Nitidus in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Lichen Nitidus: A chronic inflammatory disease characterized by shiny, flat-topped, usually flesh-colored micropapules no larger than the head of a pin. Lesions are localized in the early stages, found chiefly on the lower abdomen, penis, and inner surface of the thighs. Distribution may become generalized as the disease progresses.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cholongitas, E | 1 |
| Kokolakis, G | 1 |
| Giannikaki, E | 1 |
| Ioannidou, D | 1 |
1 other study available for dalteparin and Lichen Nitidus
| Article | Year |
|---|---|
Persistent generalized lichen nitidus successfully treated with enoxaparin sodium.
Topics: Adult; Diagnosis, Differential; Enoxaparin; Fibrinolytic Agents; Humans; Injections; Lichen Nitidus; | 2008 |